These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 4041833

  • 21. Effect of vasopressin on open field and activity behavior of the vasopressin-deficient (Brattleboro) rat.
    Williams AR, Carey RJ, Miller M.
    Peptides; 1983; 4(5):717-20. PubMed ID: 6657516
    [Abstract] [Full Text] [Related]

  • 22. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
    Nagahama S, Ann HS, Chen YF, Lindheimer MD, Oparil S.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
    [Abstract] [Full Text] [Related]

  • 23. Sympathetic nervous system and blood pressure maintenance in the Brattleboro DI rat.
    Williams JL, Johnson MD.
    Am J Physiol; 1986 May; 250(5 Pt 2):R770-5. PubMed ID: 2871766
    [Abstract] [Full Text] [Related]

  • 24. Comparison of adrenocorticotropin control in Brattleboro, Long-Evans, and Wistar rats. Measurement of corticotropin-releasing factor, arginine vasopressin, and oxytocin in hypophysial portal blood.
    Tannahill LA, Dow RC, Fairhall KM, Robinson IC, Fink G.
    Neuroendocrinology; 1988 Dec; 48(6):650-7. PubMed ID: 2855106
    [Abstract] [Full Text] [Related]

  • 25. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
    Diamant M, De Wied D.
    Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
    [Abstract] [Full Text] [Related]

  • 26. Natural killer cell activity in vasopressin-deficient rats (Brattleboro strain).
    Yirmiya R, Shavit Y, Ben-Eliyahu S, Martin FC, Weiner H, Liebeskind JC.
    Brain Res; 1989 Feb 06; 479(1):16-22. PubMed ID: 2924145
    [Abstract] [Full Text] [Related]

  • 27. Effects of prolonged vasopressin treatment in Brattleboro rats with diabetes insipidus.
    Möhring J, Kohrs G, Möhring B, Petri M, Homsy E, Haack D.
    Am J Physiol; 1978 Feb 06; 234(2):F106-11. PubMed ID: 623299
    [Abstract] [Full Text] [Related]

  • 28. Abnormal behavioural changes associated with vasopressin-induced barrel rotations.
    Boakes RJ, Ednie JM, Edwardson JA, Keith AB, Sahgal A, Wright C.
    Brain Res; 1985 Feb 04; 326(1):65-70. PubMed ID: 3971149
    [Abstract] [Full Text] [Related]

  • 29. Exogenous vasopressin modulates activity of oxytocin neurons in homozygous Brattleboro rats.
    Cheng SW, North WG.
    Am J Physiol; 1986 Nov 04; 251(5 Pt 1):E556-62. PubMed ID: 3777164
    [Abstract] [Full Text] [Related]

  • 30. Barrel rotation evoked by intracerebroventricular vasopressin injections in conscious rats. I. Description and general pharmacology.
    Wurpel JN, Dundore RL, Barbella YR, Balaban CD, Keil LC, Severs WB.
    Brain Res; 1986 Feb 12; 365(1):21-9. PubMed ID: 3947985
    [Abstract] [Full Text] [Related]

  • 31. Impaired histamine- and stress-induced secretion of ACTH and beta-endorphin in vasopressin-deficient Brattleboro rats.
    Kjaer A, Knigge U, Bach FW, Warberg J.
    Neuroendocrinology; 1993 Jun 12; 57(6):1035-41. PubMed ID: 8232762
    [Abstract] [Full Text] [Related]

  • 32. Enhanced glucose tolerance in the Brattleboro rat.
    Nakamura K, Yamashita T, Fujiki H, Aoyagi T, Yamauchi J, Mori T, Tanoue A.
    Biochem Biophys Res Commun; 2011 Feb 04; 405(1):64-7. PubMed ID: 21215256
    [Abstract] [Full Text] [Related]

  • 33. Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing arginine-vasopressin in Brattleboro rats.
    Ideno J, Mizukami H, Honda K, Okada T, Hanazono Y, Kume A, Saito T, Ishibashi S, Ozawa K.
    Mol Ther; 2003 Dec 04; 8(6):895-902. PubMed ID: 14664791
    [Abstract] [Full Text] [Related]

  • 34. High histamine levels in specific hypothalamic nuclei of Brattleboro rats lacking vasopressin.
    Correa FM, Saavedra JM.
    Brain Res; 1983 Oct 16; 276(2):247-52. PubMed ID: 6627008
    [Abstract] [Full Text] [Related]

  • 35. Angiotensin stimulates oxytocin release: imparied response in rats with genetic hypothalamic diabetes insipidus.
    Lang RE, Rascher W, Heil J, Unger T, Ganten D.
    Eur J Pharmacol; 1982 Sep 10; 83(1-2):113-7. PubMed ID: 7128694
    [Abstract] [Full Text] [Related]

  • 36. Vasopressin-induced motor effects: localization of a sensitive site in the amygdala.
    Willcox BJ, Poulin P, Veale WL, Pittman QJ.
    Brain Res; 1992 Nov 20; 596(1-2):58-64. PubMed ID: 1468003
    [Abstract] [Full Text] [Related]

  • 37. Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats.
    Engelmann M, Landgraf R.
    Physiol Behav; 1994 Jan 20; 55(1):145-9. PubMed ID: 8140159
    [Abstract] [Full Text] [Related]

  • 38. Selective blockade of vasopressin V2 receptors reveals significant V2-mediated water reabsorption in Brattleboro rats with diabetes insipidus.
    Pouzet B, Serradeil-Le Gal C, Bouby N, Maffrand JP, Le Fur G, Bankir L.
    Nephrol Dial Transplant; 2001 Apr 20; 16(4):725-34. PubMed ID: 11274265
    [Abstract] [Full Text] [Related]

  • 39. Selective cardiovascular and neuroendocrine effects of a kappa-opioid agonist in the nucleus tractus solitarii of rats.
    Carter DA, Lightman SL.
    J Physiol; 1985 Oct 20; 367():363-75. PubMed ID: 2997441
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of the pharmacologic properties of a vasopressin antagonist in Brattleboro rats.
    Mah SC, Hofbauer KG.
    J Pharmacol Exp Ther; 1988 Jun 20; 245(3):1028-32. PubMed ID: 2968448
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.